Question 1

What is the typical CAPEX range for setting up a Zinc Pyrithione manufacturing plant?

Accepted Answer

The CAPEX is USD 12 million to USD 55 million for a specialty antimicrobial plant producing zinc pyrithione.

Question 2

What is the typical plant capacity or benchmark scale for a Zinc Pyrithione manufacturing facility?

Accepted Answer

Plant capacity is 500 to 5,000 MT per year of active zinc pyrithione.

Question 3

What is the current market size and growth rate for Zinc Pyrithione?

Accepted Answer

The global zinc pyrithione market size is estimated to be around USD 170 million to USD 260 million, with a projected CAGR of 3.5% to 4.5%.

Question 4

What are the main end-use segments for Zinc Pyrithione, and what share of demand does each represent?

Accepted Answer

Anti-dandruff and scalp-care products represent 45% to 55% of demand; paints and coatings account for 20% to 25%; antimicrobial plastics, sponges, textiles, and treated articles make up 10% to 15%; and specialty preservatives, laboratory uses, and small biocide applications constitute the remaining 10% to 15%.

Question 5

What is the reaction or synthesis route and key intermediates used to manufacture Zinc Pyrithione?

Accepted Answer

The process involves the oxidation of 2-chloropyridine to 2-chloropyridine N-oxide, which is then reacted with sodium hydrosulfide or sodium sulfide under alkaline conditions to form the sodium pyrithione intermediate. This sodium pyrithione is then reacted with zinc sulfate or zinc chloride to precipitate zinc pyrithione.

Question 6

What are the key intermediate or API cost requirements, and what share of raw material cost do they represent?

Accepted Answer

Cost efficiency depends on securing competitive feedstock prices for sodium pyrithione intermediate and zinc sulfate, which together represent 60% to 75% of total raw material expense.

Question 7

What share of total capital cost do the core reaction and purification equipment represent?

Accepted Answer

The pyrithione synthesis and precipitation suite forms the largest CAPEX component, representing 35% to 50% of the total zinc pyrithione plant setup cost.

Question 8

What factors drive Zinc Pyrithione manufacturing cost the most?

Accepted Answer

The main causes of cost movement are intermediate prices, wastewater costs, and particle size rejection.

Question 9

In which regions is Zinc Pyrithione manufacturing capacity concentrated?

Accepted Answer

Manufacturing capacity is concentrated in the Asia Pacific region, mainly in China and India.

Question 10

What grades or specifications are available for Zinc Pyrithione?

Accepted Answer

Available grades include cosmetic and pharmaceutical grades, high-documentation grades for scalp-care and regulated products, and larger industrial grades for coatings and treated materials. Specifications include purity, particle size, heavy metal limits, assay, residual impurities, and microbiological quality.

Question 11

What regulatory requirements (FDA, EMA, GMP, DMF filings) apply to Zinc Pyrithione manufacturing?

Accepted Answer

Zinc pyrithione is allowed in OTC anti-dandruff products in the United States and is subject to cosmetic restrictions in the EU.

Zinc Pyrithione Manufacturing Plant Project Report 2026: Cost Analysis, ROI, and Feasibility Insights

About the Author

Vishakha Agrawal

Frequently Asked Questions